EBITDA: Income before interest, taxes, depreciation and amortization.
Neurogene Inc. (NGNE) had EBITDA of $-36.19M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-34.49M |
|
-- |
|
-- |
|
$36.67M |
|
$-36.67M |
|
$2.18M |
|
$-34.49M |
|
$-34.49M |
|
$-34.49M |
|
$-34.49M |
|
$-34.49M |
|
$-34.49M |
|
$-36.67M |
|
|
EBITDA |
$-36.19M |
22.55M |
|
22.55M |
|
$-1.53 |
|
$-1.53 |
|
| Balance Sheet Financials | |
$228.91M |
|
$11.73M |
|
$15.45M |
|
$244.36M |
|
$21.50M |
|
$0.00M |
|
$5.73M |
|
$27.23M |
|
$217.13M |
|
$217.13M |
|
$217.13M |
|
15.83M |
|
| Cash Flow Statement Financials | |
$-49.88M |
|
$52.34M |
|
$6.18M |
|
$104.18M |
|
$112.82M |
|
$8.64M |
|
$11.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.64 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-50.52M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.88% |
|
-15.88% |
|
-14.11% |
|
-15.88% |
|
$13.72 |
|
$-2.24 |
|
$-2.21 |
|